ALNYLAM PHARMACEUTICALS, INC. (32) | Intellectual Property (1)

Browse by Subcategory

License Agreements (1)

Recent Contracts

Amended and Restated ALN-AT3 Global License Terms entered into as of April 8, 2019 by and between the Registrant and Genzyme Corporation (Filed With SEC on August 6, 2019)